LyGenesis Inc. — Form D

LyGenesis Inc. of PITTSBURGH, PA, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-12. The offering totals $20.0M, of which $8.7M was reported sold. Industry: Biotechnology.

Offering

Filed: 2023-10-12
Form: D
Accession: 0000898432-23-000706
Industry: Biotechnology
Exemptions: 06b
Total offering: $20.0M
Amount sold: $8.7M
Remaining: $11.3M
Investors: 11
Date of first sale: 2023-10-05
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-494568

Issuer

Name: LyGenesis Inc.
CIK: 0001739872
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2017
Address: 1710 Murray Ave, PITTSBURGH, PA, 15217
Phone: 412-449-9983

Officers, directors & promoters (13)

Name	Role	Location
James Mellon	Director	New York, NY
Gregory Bailey	Director	Road Town, Tortola, D8
Steve Felstead	Director	Earlston, X0
Eric Lagasse	Director	Pittsburgh, PA
Eric Lagasse	Executive Officer	Pittsburgh, PA
Justin Briggs	Director	Sunnyvale, CA
Michael Hufford	Director	Pittsburgh, PA
Michael Hufford	Executive Officer	Pittsburgh, PA
Michael Hufford	Promoter	Pittsburgh, PA
Paulo Fontes	Executive Officer	Pittsburgh, PA
Paulo Fontes	Promoter	Pittsburgh, PA
Eric Legasse	Executive Officer	Pittsburgh, PA
Eric Legasse	Promoter	Pittsburgh, PA

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2024-10-11	D/A	$20.0M	$17.8M
2020-12-23	D	$20.5M	$1.9M
2019-10-22	D	$4.0M	$4.0M
2018-05-18	D	$3.2M	$2.2M

More